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Abstract:
Cancer is a rapidly growing fatal disease and with the various thiazole
compounds being scientifically generated, possible treatment options can be
implemented. Proper synthesis of 2,3-dimethoxy-1,4-benzoquinone allows for a variety
of compounds to be made with further treatment of alkylthio reagents. Both
thioacetamide and thiobenzamide are used to react with 2,3-dimethoxy-1,4benzoquinone in order to build a library of thiazoles. Final compounds can be tested for
the ability to inhibit recombinant enzyme activity and the capability to kill tumor cells. A
basic oxidation procedure along with nucleophilic attack was used to create target
products.
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Introduction:
Cancer is a worldwide epidemic that is quickly growing and spreading. Special
attention must be put on cancer research in order to put up an honest fight against its
fatal qualities. With over one hundred different types, cancer is the disease
characterized by exaggerated cell growth.1 According to the World Cancer Research
Fund International, in the year 2008, over 12.7 million new cases of cancer were
diagnosed.2 The most common type being lung cancer for men and breast cancer for
women. The majority of cancers have a very low survival rate and are highly dependent
on early detection and treatment. Andrei Gartel and his group of researchers found that
synthesized thiazole antibiotics efficiently inhibited the growth and induced potent
apoptosis in human cancer cell lines of different origin.3 Studying that research, there
seems to be a link between thiazole compounds and cancer treatment. With those
findings in mind, this project is dedicated to building various thiazole compounds in
order to find those which mimic the aforementioned inhibition of cancer cell growth.
Many chemists have devoted years of research to learn about the origins,
treatment, and prevention of this disease. Hans-René Bjørsvik and his team have tested
switchable oxidation processes leading to various pharmaceutical intermediates.4 Their
approach was to design and implement a new process for the preparation of methyland methoxy- substituted arenes which would be the building blocks for the
antioxidants, pharmaceutical chemicals, and compounds used in nutraceuticals. Using
the most activated substrate, 1,2,3-trimethoxy-5-methylbenzene, Bjørsvik and his team
achieved the highest yield.3 In our experiment, we employed a similar procedure for the
synthesis of 2,3-dimethoxy-5-methyl-1,4-benzoquinone, but instead chose to use 1,2,3-
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trimethoxybenzene (1) as our starting material. Yan-Ping Shi worked with synthesizing
flavonoids and from his work we studied the procedure, which similarly to Bjørsvik, used
(1) as a substrate to make 2, 3-dimethoxy-1,4-benzoquinone (2)1. However, our
reaction conditions will be different to achieve this compound.

MeOH

Figure 1. Experimental Design.

Following the work of Alan R. Katritzky and Wei-Qiang Fan on quinones
containing fused ring systems, we used a similar procedure designed to synthesize 2methylnaphtho[2,3-d]thiazole-4,9-dione from the thioacetamide and 2-mercapto-3amino-1,4-naphthoquinone.5 However, our project had some notable differences. First,
since our reaction will not produce HCl, we would not need to use 4-diazabicyclo
[2.2.2]octane (DABCO) as a base or dimethyl sulfoxide (DMSO) as a solvent. Instead,
methanol was used as a solvent since the reaction will generate it. Second, our
backbone compound, 2,3-dimethoxy-1,4-benzoquinone was treated with a
thioalkylamide (3) in hopes of reaching our goal of synthesizing 2-alkylbenzo[d]thiazole4,7-dione (4).
The goal of this project is to design, synthesize and evaluate 2-alkyl-5, 6bis(alkylthio)benzo[d]thiazole-4,7-dione derivatives as thioesterase (TE1) inhibitors to
block TE1 activity or be used as cyclin-dependant kinase (CDK) inhibitors. The final
compounds will be synthesized by first building a 2-alkylbenzo[d]thiazole-4, 7-dione
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library of compounds which can be later treated with alkylthiol reagents and then
converted into the final targets which will sent for testing. These compounds will be
tested in their ability to (i) inhibit recombinant enzyme activity, (ii) inhibit cellular fatty
acid synthesis or CDK inhibition, and (iii) specifically kill tumor cells.

Methods:
Experimental procedures were completed at Southern Adventist University using
standard laboratory glassware from ChemGlass or Kimble Kontes, and various reagents
obtained commercially from Alfa Aesar, Sigma-Aldrich, Acros, Anal Tech and Fisher. All
the reactions were carried out using CG-1994-Chemglass Optimag Magnetic Hot Plate
Stirrers with Safety Controls with CG-1991-P Pie Blocks, Reaction Blocks, and Safety
Holders. All solvents were evaporated using a Wilmad Lab Glass rotovap WG-EV311 or
Buchi RE 111 rotovapor. When needed, products were run on a Jeol 400 mHz NMR
Spectrometer used at the University of Tennessee Chattanooga.
Reaction 1
Synthesis of 2, 3-Dimethoxy-[1, 4]benzoquinone (2). A solution of 1,2,3trimethoxybenzene (3.20 g, 19 mmol) and acetic acid (19 mL) was added to a three
neck round bottom flask and stirred using a reflux condenser. A bubbler was set up
using nitrogen gas and mineral oil to keep an open system for the exothermic reaction.
Then, p-toluene sulfonic acid monohydrate (0.362 g, 1.9 mmol) and hydrogen peroxide
(30%, 3.24 mL, 38 mmol) were added to flask. The reaction mixture was stirred and
heated at 75°C for 30 minutes and monitored using thin-layer chromatography (TLC) by
checking the consumption of starting material and the formation of product 2. Once the
reaction was verified it was then cooled to 0°C. Nitric acid (90%, 0.41 mL, 8.7 mmol)
was added dropwise. The cold reaction mixture was poured into water and extracted
4

with dichloromethane. The organic layers were combined and washed with water to
remove residues of acetic acid, dried over anhydrous sodium sulfate and filtered.
Finally, the solvent was evaporated under reduced pressure to achieve the crude as
dark red oil.
Purification. The crude product was dissolved in boiling hexane and filtered.
Solvent was removed under reduced pressure to provide a purer compound 2. Column
chromatography was used with dry packing to further purify the product. A 20:1 ratio of
silica gel versus crude mass was calculated for the column. Silica gel was mixed with
dichloromethane and poured into the column. A 2:1 ratio of silica gel versus crude
mass was calculated for the dry pack. The gel was dissolved in the least polar solvent,
hexane, mixed with crude and evaporated under reduced pressure to obtain powder to
pack in column. The solvents used were hexane and ethyl acetate, and five 25 mL
fractions were obtained using 9:1, 8:2, and 7:3 ratios of each solvent, respectively. This
solvent system was used throughout all subsequent reactions. The selected pool
containing the desired product was evaporated under reduced pressure to obtain a
maroon solid (0.250 g, 7.81% yield).
Reaction 2
Synthesis of 2-methylbenzo[d]thiazole-4,7-dione (4a, R=Me). Once product 2
(0.07 g, 0.42 mmol) was synthesized, it was treated with thioacetamide (0.086 g, 0.63
mmol) using methanol (1 mL) as the solvent. The mixture was stirred using Pie blocks
and the reaction went to completion. The reaction was monitored using TLC. The
mixture was also further purified by means of column chromatography. Fifteen fractions
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of 8 mL each were obtained from mixture and the selected pool was evaporated under
reduced pressure (0.034 g, 63.89% yield).
Reaction 3
Synthesis of 2-phenyl-4,7-benzothiazoledine (4b, R=Ph). Using product 2
(0.05 g, 0.30 mmol), the reaction was run using thiobenzamide (0.045 g, 0.33 mmol)
and methanol (1 mL) as a solvent. The mixture was stirred using Pie blocks and the
reaction went to completion. The reaction was monitored using TLC and was further
purified by means of column chromatography. Twenty fractions of 5 mL each were
obtained from the mixture and the pool designated product from TLC plate readings was
evaporated under reduced pressure to obtain a yellow solid (0.067 g, 92.5% yield).
Reaction 4
Treatment of 2-alkylbenzo[d]thiazole-4, 7-dione using N-Acetylcysteamine.
2-phenyl-4, 7-benzothiazoledine (0.067 g, 0.278 mmol) (4b) was dissolved in methanol
(0.70 mL) and treated with N-acetylcysteamine (31 µL, 0.278 mmol). The reaction
mixture was allowed to stir for two days at a constant temperature of 60°C. Methanol
was evaporated under reduced pressure and later purified by column chromatography.7
HNMR indicated that starting material was recovered. Another attempt to synthesize the
desired targets is underway.
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Results:
Synthesis of 2, 3-Dimethoxy-[1, 4]benzoquinone.

Figure 2. NMR estimation for product 2.

Figure 3. NMR for product 2.
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Synthesis of 2-methylbenzo[d]thiazole-4,7-dione.

Figure 4. NMR estimation for product 4 with R=Me.

Figure 5. NMR results for product 4 with R=Me.
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Synthesis of 2-phenyl-4,7-benzothiazoledine.

Figure 6. NMR estimation for product 4 with R=Ph.

Figure 7. NMR data received for purified sample of product 4 with R=Ph.
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Discussion:
Various changes were made in order to improve the methods and results for
reaction 1. Pie blocks were implemented to control the temperature of the reaction but
after many tries, an open bubbler system was found to achieve better results as the
exothermic activity could be monitored via bubbling the mineral oil. Dichloromethane
was the final solvent used during the evaporation process to obtain a purer product and
subsequently, clearer NMR readings. The lower yield shown in Reaction 1 is a result of
maintaining inaccurate temperatures due to the lack of a Pie block system, possibly
causing starting material to have been burnt. However, NMR results show a very pure
product was obtained therefore the lower yield is more readily accepted.
Reaction 3 shows successful product purity and yield. The products purity relied
heavily on the fact that pure product from Reaction 1 was used and had no impurities.
Both reactions were also purified using column chromatography. Successful production
of this product allows for further nucleophilic attack on the quinone side of the molecule.
The NMR estimation is assuming that the hydrogen atoms on the quinone side are the
same, but they are not because the molecule is not symmetrical. Another reason for
purity would be that this was a short reaction and the proper conditions were
implemented for optimal results.
The results of Reaction 4 were verified by means of NMR and resulted in
recovery of starting material. This means either the reaction did not go to completion, or
simply did not work. Further oxidation reactions might have to be implemented to obtain
proper product.
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Conclusions:
According to Figure 1, the synthesis of two derivatives (R=Ph and Me) have been
achieved in this research project. Larger scale syntheses of either product will be
necessary to continue the building of the thiazole products. In order to continue this
research, further nucleophilic attack would have to be completed on either product,
resulting in the final product 5. With successful methods now developed for products 2,
and 4a with R=Me and with 4b with R=Ph, continuation of this project would expand the
library of viable heterocyclic compounds to test for cancer. Various alkylthio
nucleophiles can be used to make different versions of product 5 and once these
products have been properly synthesized; further testing can be done to assess their
chances against fighting cancer.
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